Gore Range Dental, Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1625 Miner St., Idaho Springs, CO 80452 Phone: 303-567-4412 |
George S. Douvas D.d.s. Ph.d. Dentist Medicare: Not Enrolled in Medicare Practice Location: 102 Spruce Ln, Idaho Springs, CO 80452 Phone: 303-567-0840 |
Ricks Family Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1625 Miner Street, Idaho Springs, CO 80452 Phone: 716-472-5745 |
Keysdentalco., Pllc Is Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1625 Miner St, Idaho Springs, CO 80452 Phone: 303-567-4412 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
Amgen (Nasdaq: AMGN) today announced that the Court of Appeals for the Federal Circuit affirmed the Massachusetts District Court's decision that Roche's peg-EPO product, Mircera, infringes four Amgen patents ('868, '698, '933 and '422) relating to recombinant erythropoietin (EPO) and processes for making it.
Researchers at the University of Pennsylvania have developed the first placenta-on-a-chip that can fully model the transport of nutrients across the placental barrier.
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a new tool to help surgeons use X-rays to track devices used in "minimally invasive" surgical procedures while also limiting the patient's exposure to radiation from the X-rays.
A 29-month clinical study demonstrated the long-term success of Cook Medical's Resonance® Metallic Ureteral Stent in providing drainage for patients with both benign and malignant upper urinary tract obstructions, according to results presented today at the 2010 Annual Meeting of the American Urological Association (AUA). The findings suggest that metallic stents provide adequate drainage and can be maintained in situ for 12 months without significant encrustation.
› Verified 6 days ago